Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Shares Outstanding (Diluted Average) (2019 - 2025)

Health Catalyst's Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $69.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 16.14% year-over-year to $69.9 million; the TTM value through Dec 2025 reached $69.9 million, up 16.14%, while the annual FY2025 figure was $69.9 million, 16.14% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $69.9 million in Q4 2025 per HCAT's latest filing, down from $70.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $70.4 million in Q3 2025 to a low of $43.9 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $56.9 million, with a median of $56.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 21.3% in 2022, then rose 4.27% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $47.5 million in 2021, then rose by 13.86% to $54.1 million in 2022, then increased by 4.32% to $56.4 million in 2023, then rose by 6.68% to $60.2 million in 2024, then rose by 16.14% to $69.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Shares Outstanding (Diluted Average) are $69.9 million (Q4 2025), $70.4 million (Q3 2025), and $69.6 million (Q2 2025).